Georgia Tech researchers have built a cell-free biocatalyst that converts simple one-carbon feedstocks into the amino acids serine and glycine, reaching 97% of stoichiometric yield. The system, which uses enzymes from heat-loving organisms expressed inside an E. coli lysate, represents the highest reported conversion of carbon dioxide equivalents into amino acids by any synthetic biology platform to date. Because the process sequesters more carbon than it emits, it offers a potential route to producing essential biological building blocks without the greenhouse-gas burden of conventional fermentation.
How the Biocatalyst Works
The core innovation is a cell-free expression system that sidesteps the metabolic chaos of a living cell. Instead of engineering a microbe to carry out the desired chemistry, the Georgia Tech team cracked open E. coli cells to harvest their protein-making machinery, then used that machinery to produce a set of thermophilic enzymes in a single reaction vessel. Those heat-stable enzymes, arranged as a multienzyme pathway, then catalyze the conversion of formate, bicarbonate, and ammonia into serine and glycine.
A persistent problem in cell-free work is that leftover E. coli enzymes compete for the same cofactors and chemical intermediates the target pathway needs. The Georgia Tech system addresses this by exploiting the temperature gap between mesophilic host enzymes and the thermophilic production enzymes. After gene expression is complete, raising the temperature impedes the siphoning of intermediates and cofactors by the E. coli background machinery, effectively silencing competing reactions while the heat-tolerant enzymes keep working. That thermal switch is a key reason the system achieves such high yield.
97% Yield and What It Means
The 97% figure refers to stoichiometric yield, meaning nearly every carbon atom fed into the system ends up incorporated into an amino acid product. That number, reported in ACS Synthetic Biology, sets a new benchmark. Previous cell-free approaches to amino acid synthesis from carbon dioxide produced far lower titers. An earlier in vitro cascade based on the reductive glycine pathway with electrochemical cofactor regeneration, for instance, achieved only sub-millimolar glycine, a useful proof of concept but orders of magnitude below what would be needed for commercial production.
The Georgia Tech result is, by the team’s own account, the highest reported conversion of CO2 equivalents into amino acids using any synthetic biology system. “To our knowledge, it’s the first time anyone has synthesized amino acids in a carbon-negative way using this type of biocatalyst,” the researchers stated when the foundational method was first described. The newer work, which builds on a method the team pioneered in 2024, solves the efficiency bottleneck that had limited earlier iterations and demonstrates that nearly quantitative carbon capture into useful molecules is possible in a single pot.
Why Heat-Loving Enzymes Changed the Equation
“We wondered if introducing enzymes from thermophilic organisms could boost efficiency,” said Pamela Peralta-Yahya, a chemical and biomolecular engineering professor at Georgia Tech. The answer turned out to be decisive. Thermophilic enzymes remain active at temperatures that denature the host cell’s own proteins, creating a clean catalytic environment once the expression phase is over. “But to create a commercially viable system, we needed to increase the system’s efficiency and reduce the cost of the team’s previous system,” Peralta-Yahya noted.
That dual challenge, performance and cost, is where the thermal trick pays off twice. By deactivating competing host enzymes through heat rather than through expensive purification steps, the team avoids the labor-intensive protein isolation that makes many cell-free systems impractical at scale. The result is a streamlined workflow: express enzymes, raise the temperature, add feedstocks, and collect product. In principle, this strategy could be adapted to other biosynthetic cascades that currently suffer from side reactions in crude lysates.
Carbon-Negative Production in Context
Traditional amino acid manufacturing relies on sugar-fed microbial fermentation, a process that consumes agricultural feedstocks and generates carbon emissions at every step, from farming to reactor aeration. The Georgia Tech system flips that equation. Its inputs (formate, bicarbonate, and ammonia) can be derived from captured carbon dioxide, and the overall process sequesters more carbon than it emits.
That carbon-negative profile places it in a growing family of technologies that treat CO2 as a raw material rather than a waste product. Separate research has demonstrated routes from CO2 and electricity to acetate and then to microbial biomass protein, but those systems depend on living organisms and face the metabolic inefficiencies that come with keeping cells alive. The cell-free approach strips away growth, reproduction, and maintenance energy, directing virtually all chemical energy toward the target product. Recent reviews of cell-free metabolic engineering have highlighted one-carbon substrate conversions and coupling to renewable power sources as a particularly promising direction, and the Georgia Tech results now provide concrete efficiency data to support that thesis.
Scaling Challenges Ahead
Despite the impressive yields, significant hurdles remain before this chemistry can leave the lab. One issue is enzyme cost: even when produced in crude lysates, thermophilic proteins must be expressed at high levels and remain stable over long reaction times. Another is cofactor management. The current system relies on a carefully balanced mix of ATP, NADH, and other small molecules that can be expensive at industrial scales. Integrating in situ cofactor regeneration or electrochemical recycling could help, but those additions complicate reactor design.
There is also the question of volumetric productivity. Stoichiometric yield describes how efficiently atoms are used, not how fast product accumulates. For commodity amino acids, factories must achieve high titers and space-time yields to be economically competitive with fermentation. Continuous-flow reactors, immobilized enzyme systems, or modular reaction stages may be needed to translate the Georgia Tech design into a process that can run for days or weeks without loss of activity.
Regulatory and safety considerations will play a role as well. While cell-free systems avoid the release of genetically modified organisms, they still involve engineered DNA constructs and concentrated enzyme mixtures. Existing frameworks for enzyme-based manufacturing, many of which are cataloged in resources such as the National Center for Biotechnology database, suggest that regulatory pathways are navigable but will require detailed characterization of impurities and byproducts.
Positioning Within the Research Landscape
The Georgia Tech platform also reflects broader trends in how biological research is organized and shared. Many synthetic biology groups now maintain curated online libraries of plasmids, enzyme variants, and pathway designs, similar in spirit to personalized collections in tools like MyNCBI profiles. These collections allow teams to track which constructs have been tested, which conditions worked, and how different modules perform when recombined.
As cell-free systems become more complex, researchers are increasingly treating pathways as modular parts that can be mixed and matched. Annotated bibliographies and shared datasets, analogous to the structured reference collections used for literature management, make it easier to compare yields, cofactor strategies, and feedstock choices across labs. Transparent reporting of both successes and failures will be essential if carbon-negative amino acid synthesis is to move from a handful of case studies to a widely adopted platform.
On the practical side, teams developing similar biocatalysts will have to consider data stewardship and access control. Laboratory notebooks, sequence files, and reactor logs increasingly live in cloud systems that mirror the account-based structures seen in scientific portals, including configurable privacy settings for what is shared publicly or kept internal. Thoughtful policies around openness could accelerate progress on carbon-negative chemistry while still protecting intellectual property where necessary.
For now, the Georgia Tech work stands as a proof that near-perfect carbon efficiency is achievable in a cell-free format using simple one-carbon inputs. If researchers can solve the remaining challenges of enzyme cost, cofactor recycling, and reactor design, the same principles may extend beyond serine and glycine to a broader portfolio of chemicals. In that scenario, carbon dioxide would shift from a climate liability to a primary feedstock for manufacturing, and heat-loving enzymes in cracked-open bacteria could become unlikely cornerstones of a more sustainable chemical industry.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
